收藏切换
Comparison of General Technical Requirements for Similar Content Published by Pharmacopoeia Agencies and Drug Regulatory Agencies in China, United States, Europe, and Japan
收藏切换
PDF
Xinyi XU1, Wenli YU2, Dan LI3, Guannan WANG4, Heng LI5, Yun WANG6, Zhen LIU7, Leran TAO8, Haoyun SONG9, Zhaopeng YANG1, *
Chinese Pharmaceutical Journal | 2024, 59(18) : 1764 - 1772
Less
收藏切换
Chinese Pharmaceutical Journal | 2024, 59(18): 1764-1772
Comparison of General Technical Requirements for Similar Content Published by Pharmacopoeia Agencies and Drug Regulatory Agencies in China, United States, Europe, and Japan
Full
Xinyi XU1, Wenli YU2, Dan LI3, Guannan WANG4, Heng LI5, Yun WANG6, Zhen LIU7, Leran TAO8, Haoyun SONG9, Zhaopeng YANG1, *
Affiliations
  • 1 Chinese Pharmacopoeia Commission, Beijing 100061, China
  • 2 Organon (Shanghai) Pharmaceutical Technology Co., Ltd, Shanghai 200030, China
  • 3 MSD Research and Development (China) Co., Ltd, Beijing 100012, China
  • 4 Bayer Healthcare Co., Ltd, Beijing 100176, China
  • 5 Merck Serrano (Beijing) Pharmaceutical Research and Development Co., Ltd, Beijing 100016, China
  • 6 China Association of Enterprises with Foreign Investment R&D-based Pharmaceutical Association Committee, Beijing 100125, China
  • 7 Jiangxi Institute for Drug Control, Nanchang 330029, China
  • 8 School of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, China
  • 9 National Institutes for Food and Drug Control, Beijing 102629, China
Published: 2024-09-22 doi: 10.11669/cpj.2024.18.013
Outline
收藏切换

OBJECTIVE To provide reference and guidance for improving the development mechanism and content of guidelines (general technical requirements) for similar content published by Chinese pharmacopoeia commission and drug regulatory agency. METHODS By reviewing the similar guidelines (general technical requirements) published by pharmacopoeia commissions and drug regulatory agencies in China, the United States, Europe, and Japan, a comparison and analysis were conducted on their similarities, differences, and mutual references in terms of their development purposes, scope of application, and specific content. RESULTS In terms of preparations, biological products, stability, impurities, dissolution, microbiological testing methods, and validation of analytical methods, pharmacopoeia commissions and drug regulatory agencies in China, the United States, Europe, and Japan have similar guidelines (general technical requirements), and there are differences in the purposes and focuses. Except for China, other countries or regions have less repetitive content and no conflicting content in the guidelines (general technical requirements) for similar content published by pharmacopoeia commissions and drug regulatory agencies. The two complement each other and jointly support the drug standard system. CONCLUSION It is recommended that China's drug regulatory agency take the lead in determining the subjects, further optimizing and improving the harmonization mechanism, and harmonizing and unifying the guidelines (general technical requirements) developed by pharmacopoeia commission and drug regulatory agency based on the functions of each agency, to ensure that the two are clearly positioned in terms of development purposes, scope of application, and content. Strengthen the interoperability of similar content guidelines published by pharmacopoeia agency and drug regulatory agency and keep pace with international standards.

pharmacopoeia  /  regulation  /  guideline  /  general technical requirement  /  comparison
Xinyi XU, Wenli YU, Dan LI, Guannan WANG, Heng LI, Yun WANG, Zhen LIU, Leran TAO, Haoyun SONG, Zhaopeng YANG. Comparison of General Technical Requirements for Similar Content Published by Pharmacopoeia Agencies and Drug Regulatory Agencies in China, United States, Europe, and Japan[J]. Chinese Pharmaceutical Journal, 2024 , 59 (18) : 1764 -1772 . DOI: 10.11669/cpj.2024.18.013
Year 2024 volume 59 Issue 18
PDF
138
67
Cite this Article
BibTeX
Article Info
doi: 10.11669/cpj.2024.18.013
  • Receive Date:2024-01-20
  • Online Date:2025-12-30
  • Published:2024-09-22
Article Data
Affiliations
History
  • Received:2024-01-20
Funding
Affiliations
    1 Chinese Pharmacopoeia Commission, Beijing 100061, China
    2 Organon (Shanghai) Pharmaceutical Technology Co., Ltd, Shanghai 200030, China
    3 MSD Research and Development (China) Co., Ltd, Beijing 100012, China
    4 Bayer Healthcare Co., Ltd, Beijing 100176, China
    5 Merck Serrano (Beijing) Pharmaceutical Research and Development Co., Ltd, Beijing 100016, China
    6 China Association of Enterprises with Foreign Investment R&D-based Pharmaceutical Association Committee, Beijing 100125, China
    7 Jiangxi Institute for Drug Control, Nanchang 330029, China
    8 School of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, China
    9 National Institutes for Food and Drug Control, Beijing 102629, China
References
Share
https://castjournals.cast.org.cn/joweb/zgyxzz/EN/10.11669/cpj.2024.18.013
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT